Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000202298

Medchemexpress LLC Py-maa-val-cit-pab-mmae | 2247398-68-9 | 98.5% | 1446.79 | C72H111N13O16S | 50 MG
SDP

Catalog No. 5000202298
Encompass_Preferred

Py-MAA-Val-Cit-PAB-MMAE is a drug-linker conjugate used as a building block in antibody-drug conjugate (ADC) synthesis. It links the cytotoxic payload MMAE to a protease-cleavable Val-Cit-PAB linker via a Py-MAA spacer and is intended for research use in ADC development.

  • Protease-cleavable Val-Cit-PAB linker for controlled payload release
  • Contains a Py-MAA spacer for conjugation flexibility
  • Includes monomethyl auristatin E (MMAE) as the cytotoxic payload
  • Supplied as a dry material suitable for organic solvent handling
  • Intended for research and development applications in ADC synthesis

Catalog No. 50-002-02298 Supplier Medchemexpress LLC Supplier No. HY14887550MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Py-MAA-Val-Cit-PAB-MMAE is a drug-linker conjugate used as a building block in antibody-drug conjugate (ADC) synthesis. It links the cytotoxic payload MMAE to a protease-cleavable Val-Cit-PAB linker via a Py-MAA spacer and is intended for research use in ADC development.

  • Protease-cleavable Val-Cit-PAB linker for controlled payload release
  • Contains a Py-MAA spacer for conjugation flexibility
  • Includes monomethyl auristatin E (MMAE) as the cytotoxic payload
  • Supplied as a dry material suitable for organic solvent handling
  • Intended for research and development applications in ADC synthesis

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.